0001178913-26-004334 Sample Contracts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 31st, 2026 • BioLineRx Ltd. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of August 27, 2026, between BioLineRx Ltd., a company organized under the laws of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • August 31st, 2026 • BioLineRx Ltd. • Pharmaceutical preparations • New York
WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES BIOLINERX LTD.Warrant Agreement • August 31st, 2026 • BioLineRx Ltd. • Pharmaceutical preparations
THIS WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES (this "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on August [*], 20311 (the "Termination Date") but not thereafter, to subscribe for and purchase from BIOLINERX LTD., a company organized under the laws of the State of Israel (the "Company"), up to _______ Ordinary Shares, par value NIS 0.10 per share, of the Company (the "Warrant Shares"), represented by American Depositary Shares (each, an "ADS" and, collectively, the "ADSs" and the ADSs issuable upon exercise of this Warrant, the "Warrant ADSs"), as subject to adjustment hereunder. The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined in Section 2(b).
PRE-FUNDED WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES BIOLINERX LTD.Pre-Funded Warrant Agreement • August 31st, 2026 • BioLineRx Ltd. • Pharmaceutical preparations
THIS PRE-FUNDED WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES (this "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the "Initial Exercise Date") and until this Warrant is exercised in full (the "Termination Date") but not thereafter, to subscribe for and purchase from BIOLINERX LTD., a company organized under the laws of the State of Israel (the "Company"), up to _______ Ordinary Shares, par value NIS 0.10 per share, of the Company (the "Warrant Shares"), represented by American Depositary Shares (each, an "ADS" and, collectively, the "ADSs" and the ADSs issuable upon exercise of this Warrant, the "Warrant ADSs"), as subject to adjustment hereunder. The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined in Section 2(b).
AMENDMENT TO WARRANTSWarrant Amendment • August 31st, 2026 • BioLineRx Ltd. • Pharmaceutical preparations
This Amendment to the Warrant to Purchase American Depositary Shares (this “Amendment”) dated this 27th day of August, 2026, by and between BIOLINERX LTD., a company organized under the laws of the State of Israel (the “Company”), and Armistice Capital Master Fund Ltd. (the “Holder”).